ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $410 | -94.4% | 257,584 | -78.0% | 0.00% | -97.2% |
| Q4 2022 | $7,300 | -99.7% | 1,171,799 | +221.1% | 0.11% | +231.2% |
| Q3 2022 | $2,445,000 | +1498.0% | 364,951 | +1420.2% | 0.03% | +1500.0% |
| Q2 2022 | $153,000 | -22.3% | 24,007 | -43.5% | 0.00% | 0.0% |
| Q1 2022 | $197,000 | +181.4% | 42,506 | +201.9% | 0.00% | +100.0% |
| Q4 2021 | $70,000 | -90.8% | 14,079 | -77.8% | 0.00% | -90.0% |
| Q3 2021 | $765,000 | – | 63,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |